Ebola is so infectious that patients need to be treated in isolation by staff wearing protective clothing.
More on Ebola
- Crisis info
- What is Ebola? Skip to our guide
- Read the latest updates from the frontline
- Ebola treatment centre - interactive graphic
- Explore our Ebola outbreak timeline
- Read our Ebola blog
Since the Ebola outbreak in West Africa was officially declared on 22nd March in Guinea, it has claimed more than 8,600 lives in the region.
The outbreak is the largest ever, and is currently affecting three countries in West Africa: Guinea, Liberia and Sierra Leone. Outbreaks in Mali, Nigeria and Senegal have been declared over. A separate outbreak in Democratic Republic of Congo has also ended.
Downward trend in cases
During the last weeks, a downward trend of new cases has been reported in Médecins Sans Frontières/Doctors Without Borders (MSF) Ebola management centres across the three affected countries, with 50 confirmed cases in its eight centres last week.
While this is a promising development, the World Health Organisation reported that only about half of new cases in both Guinea and Liberia are from known Ebola contacts, while in Sierra Leone there is no data available.
There is almost no information sharing for tracing Ebola contacts between the three most-affected countries. Since a single new case is enough to reignite an outbreak, the level of vigilance should remain high in order not to jeopardise the progress made in stemming the epidemic.
MSF's Ebola response
Since the response began, 27 MSF staff members have fallen ill with Ebola, 14 of whom have recovered and 13 have died.
The vast majority of these infections were found to have occurred in the community.
Since the beginning of our Ebola response, we have sent more than 1,400 tonnes of cargo to West Africa.
Read an extensive interview with an MSF Ebola specialist about how we care for our Ebola patients.
MSF case numbers since the outbreak began (as of 30th January)
- Admitted* more than 8,100 patients
- Around 4,960 were confirmed as having Ebola
- More than 2,300 patients have survived
* Admissions include all suspected, probable and confirmed cases.
Hover over the image below for an interactive guide to an MSF Ebola treatment centre
Hover over the image below for an interactive guide to the high risk zone inside an MSF Ebola treatment centre
Hover over the image below for an interactive guide to our Ebola protective kit
It is estimated there had been over 1,800 cases of Ebola, with nearly 1,300 deaths, before this latest outbreak in 2014.
The Ebola virus was first associated with an outbreak of 318 cases of a haemorrhagic disease in Zaire (now the Democratic Republic of Congo) in 1976. Of the 318 cases, 280 died — and died quickly.
That same year, 284 people in Sudan also became infected with the virus, killing 156.
There are five different strains of the Ebola virus: Bundibugyo, Ivory Coast, Reston, Sudan and Zaire, named after their places of origin.
Four of these five have caused disease in humans. While the Reston virus can infect humans, no illnesses or deaths have been reported.
Risk of Ebola spreading
The risk of Ebola spreading to the UK is minimal, but to minimise it even further we need more resources to bring the outbreak under control in West Africa.
Before this outbreak, MSF has treated hundreds of people affected by Ebola in Uganda, Republic of Congo, the Democratic Republic of Congo (DRC), Sudan, Gabon and Guinea. In 2007, MSF entirely contained an epidemic of Ebola in Uganda.
What causes Ebola?
Ebola can be caught from both humans and animals. It is transmitted through close contact with blood, secretions, or other bodily fluids.
Healthcare workers have frequently been infected while treating Ebola patients. This has occurred through close contact without the use of gloves, masks or protective goggles.
In areas of Africa, infection has been documented through the handling of infected chimpanzees, gorillas, fruit bats, monkeys, forest antelope and porcupines found dead or ill in the rainforest.
Burials where mourners have direct contact with the deceased can also transmit the virus, whereas transmission through infected semen can occur up to seven weeks after clinical recovery.
No specific treatment or vaccine is yet available for Ebola
Symptoms of Ebola
Early on, symptoms are non-specific, making it difficult to diagnose.
The disease is often characterised by the sudden onset of fever, feeling weak, muscle pain, headaches and a sore throat. This is followed by vomiting, diarrhoea, rash, impaired kidney and liver function and, in some cases, internal and external bleeding.
Symptoms can appear from two to 21 days after exposure. Some patients may go on to experience rashes, red eyes, hiccups, chest pains, difficulty breathing and swallowing.
MSF UK doctor Javid Abdulmoneim reflects on his time battling Ebola in Sierra Leone in this powerful and painful TEDxAthens talk
Diagnosing Ebola is difficult because the early symptoms, such as red eyes and rashes, are common.
Ebola infections can only be diagnosed definitively in the laboratory by five different tests.
Such tests are an extreme biohazard risk and should be conducted under maximum biological containment conditions. A number of human-to-human transmissions have occurred due to a lack of protective clothing.
“Health workers are particularly susceptible to catching it so, along with treating patients, one of our main priorities is training health staff to reduce the risk of them catching the disease whilst caring for patients,” said Henry Gray, MSF’s emergency coordinator, during an outbreak of Ebola in Uganda in 2012.Henry is also working on the current outbreak.
“We have to put in place extremely rigorous safety procedures to ensure that no health workers are exposed to the virus – through contaminated material from patients or medical waste infected with Ebola.”
No specific treatment or vaccine is yet available for Ebola.
Standard treatment for Ebola is limited to supportive therapy. This consists of hydrating the patient, maintaining their oxygen status and blood pressure and treating them for any complicating infections.
Despite the difficulty of diagnosing Ebola in its early stages, those who display its symptoms should be isolated and public health professionals notified.
Supportive therapy can continue with proper protective clothing until samples from the patient are tested to confirm infection.
Once a patient recovers from Ebola, they are immune to the strain of the virus they contracted.
MSF contained an outbreak of Ebola in Uganda in 2012 by placing a control area around the treatment centre.
An Ebola outbreak is officially considered at an end once 42 days have elapsed without any new confirmed cases.
Read an extensive interview with an MSF Ebola specialist about how we care for our Ebola patients.
Meet Lumatu Samura, 16, one of the few pregnant women to survive Ebola at an MSF treatment centre.
Update 4th February 2015
A trial of the experimental Ebola drug brincidofovir in Liberia has been halted due to a significant drop in the number of new Ebola cases, coupled with the 30th January announcement by the drug’s manufacturer that it would no longer participate in the trial.
Update 28th January 2015
A new maternity unit for pregnant women with Ebola – or those suspected of having Ebola – has been opened within an Ebola treatment centre in Sierra Leone by MSF.
Update 26th January 2015
A downward trend of new cases is reported in MSF Ebola management centres across West Africa with just over 50 patients currently under our care. While this is a promising development, we caution that a loss of vigilance now would jeopardise the progress made in stemming the epidemic.
Update 8th January 2015
We have begun to admit our first patients to a new Ebola Treatment Centre in Kissy, an Ebola hotspot on the outskirts of Freetown, Sierra Leone.
Update 1st January 2015
A clinical trial for an anti-viral drug has started to test whether it can be used as a possible treatment for Ebola. The trial is led by Oxford University and is being held at the MSF treatment centre in Monrovia, Liberia.
Update 18th December 2014
To increase access to care for Ebola patients in western Sierra Leone, which has been hit hard by the current outbreak, we have opened new Ebola treatment centres in Freetown and Magburaka.
Update 17th December 2014
A clinical trial for a possible treatment for Ebola started in Guinea today, taking place at MSF’s Ebola Treatment Centre in Guéckédou, in the east of the country.
Update 12th December 2014
The Ebola outbreak has improved in Lofa County, Liberia, to the extent that Médecins Sans Frontières/Doctors Without Borders (MSF) has now decided to withdraw from the area.
Since 30th October there have been no new patients in the Ebola management centre (EMC) in Foya, this means that, as new organisations arrive to aid the response, the need for MSF’s response is greatly reduced.
The success this intervention in northern Liberia has benefited from a comprehensive approach and constant community involvement and can, therefore, be considered a model example of an effective response.
Update 10th December 2014
As part of our ongoing emergency response to Ebola we have carried out the largest-ever distribution of antimalarials in Sierra Leone, alongside the Ministry of Health.
Teams distributed 1.5 million antimalarial treatments to residents of Freetown and five districts in the surrounding Western Area over four days, with the aim of protecting people from malaria during the disease’s peak season.
“In the context of Ebola, malaria is a major concern, because people who are sick with malaria have the same symptoms as people sick with Ebola,” said Patrick Robitaille, MSF field coordinator in Freetown.
Update 5th December 2014
We have set up a 10-bed Ebola Transit Unit in a densely populated slum on the outskirts of Monrovia, Liberia. The unit is near Redemption Hospital, which has been closed since October due to the Ebola epidemic. We hope the unit will help the hospital to reopen safely.
Update 2nd December 2014
MSF warned today that the international community must not fail twice with a response that is slow in the first instance and ill-adapted later on, relying on NGOs, local citizens and governments instead.
Related News & Publications
Fundraise for MSF
Set yourself a challenge for 2015 and fundraise for MSF.